Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 211 AL 225

Proximity-Induced Pharmacology for Amyloid-Related Diseases

Bertran-Mostazo A, Putriūtė G, Álvarez-Berbel I, Busquets MA, Galdeano C, Espargaró A, Sabate R.

Cells. 2024 Mar 4;13(5):449. doi: 10.3390/cells13050449.

Utilizing Extracellular Vesicles for Eliminating 'Unwanted Molecules': Harnessing Nature's Structures in Modern Therapeutic Strategies

Kisielewska M, Rakoczy K, Skowron I, Górczyńska J, Kacer J, Bocheńska A, Choromańska A.

Molecules. 2024 Feb 21;29(5):948. doi: 10.3390/molecules29050948.

Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial

Howard R, Cort E, Rawlinson C, Wiegand M, Downey A, Lawrence V, Banerjee S, Bentham P, Fox C, Harwood R, Hunter R, Livingston G, Moniz-Cook E, Panca M, Raczek M, Ivenso C, Russell G, Thomas A, Wilkinson P, Freemantle N, Gould R.

Alzheimers Dement. 2024 Apr;20(4):2990-2999. doi: 10.1002/alz.13766. Epub 2024 Mar 13.

Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease

Peddinti V, Avaghade MM, Suthar SU, Rout B, Gomte SS, Agnihotri TG, Jain A.

Clin Nutr ESPEN. 2024 Apr;60:266-280. doi: 10.1016/j.clnesp.2024.02.019. Epub 2024 Feb 19.

Research Progress of Mitophagy in Alzheimer's Disease

Yao J, Kan B, Dong Z, Tang Z.

Curr Alzheimer Res. 2024;20(12):827-844. doi: 10.2174/0115672050300063240305074310.

Lecanemab Questions

Nadeau SE.

Neurology. 2024 Apr 9;102(7):e209320. doi: 10.1212/WNL.0000000000209320. Epub 2024 Mar 14.

Lecanemab for Alzheimer Disease: Is It Worth It?

Nelson SE, Lopez OL.

Neurology. 2024 Apr 9;102(7):e209265. doi: 10.1212/WNL.0000000000209265. Epub 2024 Mar 14.

Somatostatin and the pathophysiology of Alzheimer's disease

Almeida VN.

Ageing Res Rev. 2024 Apr;96:102270. doi: 10.1016/j.arr.2024.102270. Epub 2024 Mar 13.

A review of the advances, insights, and prospects of gene therapy for Alzheimer's disease: A novel target for therapeutic medicine

Ataei B, Hokmabadi M, Asadi S, Asadifard E, Aghaei Zarch SM, Najafi S, Bagheri-Mohammadi S.

Gene. 2024 Jun 20;912:148368. doi: 10.1016/j.gene.2024.148368. Epub 2024 Mar 12.

An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease

Zhang X, Gomez L, Below JE, Naj AC, Martin ER, Kunkle BW, Bush WS.

J Alzheimers Dis. 2024;98(3):1053-1067. doi: 10.3233/JAD-231075.

The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease

Shen Z, Yang X, Lan Y, Chen G.

J Alzheimers Dis. 2024;98(3):741-754. doi: 10.3233/JAD-231159.

Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects

Aljassabi A, Zieneldien T, Kim J, Regmi D, Cao C.

J Alzheimers Dis. 2024;98(3):755-772. doi: 10.3233/JAD-231163.

Role of Cytoskeletal Elements in Regulation of Synaptic Functions: Implications Toward Alzheimer's Disease and Phytochemicals-Based Interventions

Verma H, Kaur S, Kaur S, Gangwar P, Dhiman M, Mantha AK.

Mol Neurobiol. 2024 Oct;61(10):8320-8343. doi: 10.1007/s12035-024-04053-3. Epub 2024 Mar 16.

Alzheimer's disease and clinical trials

Paul D, Agrawal R, Singh S.

J Basic Clin Physiol Pharmacol. 2024 Mar 18;35(1-2):31-44. doi: 10.1515/jbcpp-2023-0264. eCollection 2024 Jan 1.

Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid

Meyer MR, Kirmess KM, Eastwood S, Wente-Roth TL, Irvin F, Holubasch MS, Venkatesh V, Fogelman I, Monane M, Hanna L, Rabinovici GD, Siegel BA, Whitmer RA, Apgar C, Bateman RJ, Holtzman DM, Irizarry M, Verbel D, Sachdev P, Ito S, Contois J, Yarasheski KE, Braunstein JB, Verghese PB, West T.

Alzheimers Dement. 2024 May;20(5):3179-3192. doi: 10.1002/alz.13764. Epub 2024 Mar 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias